Article
20 Dec 2023
Denosumab Biosimilar Updates
AUTHORS CONTENT
Article
14 Nov 2023
Formycon Enjoined From Manufacturing FYB202 Biosimilar Of STELARA In Germany
Article
03 Oct 2023
Katalin Karikó And Drew Weissman Awarded Nobel Prize In Physiology Or Medicine For Discoveries Relating To MRNA Vaccines
Article
01 Sep 2023
Celltrion Stelara (Ustekinumab) Settlement With J&J
Article
27 Jul 2023
Teva And Alvotech Expand Strategic Biosimilars Partnership
Article
22 Jun 2023
Celltrion And Rani Therapeutics To Jointly Develop Oral Formulation Of Adalimumab Biosimilar
Article
15 Jun 2023
Alvotech And Teva Reach Ustekinumab (STELARA) Settlement With J&J
Article
26 May 2023
Janssen And Amgen Settle STELARA (Ustekinumab) BPCIA Litigation
Article
21 Apr 2023
REMICADE Antitrust Settlement Receives Final Approval
Article
03 Mar 2023
Alteogen And Sandoz Enter A Biosimilars Agreement Relating To Subcutaneous Products
Article
23 Nov 2022
FDA Approves Eli Lilly's REZVOGLAR As The Second Interchangeable Insulin Glargine
Article
26 Oct 2022
Biosimilars Licensing Agreement Updates
Article
15 Sep 2022
Apotex Files IPR Petition On Aflibercept Patent
Article
08 Jul 2022
Update On Xbrane's Ranibizumab Application
Article
03 Jun 2022
FDA Annual Public Meeting Regarding User Fees
Article
30 Mar 2022
JHL Biotech Co-Founders Sentenced To Jail For Theft Of Trade Secrets
Article
22 Nov 2004
Top Ten Things to Do About Your Competitors’ Intellectual Property